BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10201843)

  • 1. Dibasic benzo[B]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 4. SAR studies on the conformationally restricted C3-side chain of hydroxybenzo[B]thiophenes.
    Takeuchi K; Kohn TJ; Sall DJ; Denney ML; McCowan JR; Smith GF; Gifford-Moore DS
    Bioorg Med Chem Lett; 1999 Mar; 9(5):759-64. PubMed ID: 10201843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diamino benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors. Part 6: further focus on the contracted C4'-side chain analogues.
    Takeuchi K; Kohn TJ; Harper RW; Lin HS; Gifford-Moore DS; Richett ME; Sall DJ; Smith GF; Zhang M
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1199-202. PubMed ID: 10866380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dibasic benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 2. Sidechain optimization and demonstration of in vivo efficacy.
    Zhang M; Bailey DL; Bastian JA; Briggs SL; Chirgadze NY; Clawson DK; Denney ML; Gifford-Moore DS; Harper RW; Johnson LM; Klimkowski VJ; Kohn TJ; Lin HS; McCowan JR; Richett ME; Sall DJ; Smith AJ; Smith GF; Snyder DW; Takeuchi K; Utterback BG; Yan SC
    Bioorg Med Chem Lett; 1999 Mar; 9(5):775-80. PubMed ID: 10201846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dibasic benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors. 2. Exploring interactions at the proximal (S2) binding site.
    Sall DJ; Briggs SL; Chirgadze NY; Clawson DK; Gifford-Moore DS; Klimkowski VJ; McCowan JR; Smith GF; Wikel JH
    Bioorg Med Chem Lett; 1998 Sep; 8(18):2527-32. PubMed ID: 9873574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diamino benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 3. Enhancing activity by imposing conformational restriction in the C-4" side chain.
    Bastian JA; Chirgadze N; Denney ML; Gifford-Moore DS; Sall DJ; Smith GF; Wikel JH
    Bioorg Med Chem Lett; 1999 Feb; 9(3):363-8. PubMed ID: 10091685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dibasic benzo[b]thiophene derivatives as a novel class of active site-directed thrombin inhibitors. 1. Determination of the serine protease selectivity, structure-activity relationships, and binding orientation.
    Sall DJ; Bastian JA; Briggs SL; Buben JA; Chirgadze NY; Clawson DK; Denney ML; Giera DD; Gifford-Moore DS; Harper RW; Hauser KL; Klimkowski VJ; Kohn TJ; Lin HS; McCowan JR; Palkowitz AD; Smith GF; Takeuchi K; Thrasher KJ; Tinsley JM; Utterback BG; Yan SC; Zhang M
    J Med Chem; 1997 Oct; 40(22):3489-93. PubMed ID: 9357512
    [No Abstract]   [Full Text] [Related]  

  • 7. The crystal structures of human alpha-thrombin complexed with active site-directed diamino benzo[b]thiophene derivatives: a binding mode for a structurally novel class of inhibitors.
    Chirgadze NY; Sall DJ; Briggs SL; Clawson DK; Zhang M; Smith GF; Schevitz RW
    Protein Sci; 2000 Jan; 9(1):29-36. PubMed ID: 10739244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diamino benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors. 5. Potency, efficacy, and pharmacokinetic properties of modified C-3 side chain derivatives.
    Sall DJ; Bailey DL; Bastian JA; Buben JA; Chirgadze NY; Clemens-Smith AC; Denney ML; Fisher MJ; Giera DD; Gifford-Moore DS; Harper RW; Johnson LM; Klimkowski VJ; Kohn TJ; Lin HS; McCowan JR; Palkowitz AD; Richett ME; Smith GF; Snyder DW; Takeuchi K; Toth JE; Zhang M
    J Med Chem; 2000 Feb; 43(4):649-63. PubMed ID: 10691691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzo[b]thiophene-based histone deacetylase inhibitors.
    Witter DJ; Belvedere S; Chen L; Secrist JP; Mosley RT; Miller TA
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4562-7. PubMed ID: 17576064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of thiophene and benzo[b]thiophene analogs of combretastatin A-4 and isocombretastatin A-4: A comparison between the linkage positions of the 3,4,5-trimethoxystyrene unit.
    Do CV; Faouzi A; Barette C; Farce A; Fauvarque MO; Colomb E; Catry L; Berthier-Vergnes O; Haftek M; Barret R; Lomberget T
    Bioorg Med Chem Lett; 2016 Jan; 26(1):174-80. PubMed ID: 26602281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzo[b]thiophene-2-carboxamide derivatives as potent urotensin-II receptor antagonists.
    Lim CJ; Woo SE; Ko SI; Lee BH; Oh KS; Yi KY
    Bioorg Med Chem Lett; 2016 Oct; 26(19):4684-4686. PubMed ID: 27597245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of urokinase by 4-substituted benzo[b]thiophene-2-carboxamidines: an important new class of selective synthetic urokinase inhibitor.
    Towle MJ; Lee A; Maduakor EC; Schwartz CE; Bridges AJ; Littlefield BA
    Cancer Res; 1993 Jun; 53(11):2553-9. PubMed ID: 8495419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for potent inhibition of d-amino acid oxidase by thiophene carboxylic acids.
    Kato Y; Hin N; Maita N; Thomas AG; Kurosawa S; Rojas C; Yorita K; Slusher BS; Fukui K; Tsukamoto T
    Eur J Med Chem; 2018 Nov; 159():23-34. PubMed ID: 30265959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synthesis of three 4-substituted benzo[b]thiophene-2-carboxamidines as potent and selective inhibitors of urokinase.
    Bridges AJ; Lee A; Schwartz CE; Towle MJ; Littlefield BA
    Bioorg Med Chem; 1993 Dec; 1(6):403-10. PubMed ID: 8087561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships of substituted benzothiophene-anthranilamide factor Xa inhibitors.
    Chou YL; Davey DD; Eagen KA; Griedel BD; Karanjawala R; Phillips GB; Sacchi KL; Shaw KJ; Wu SC; Lentz D; Liang AM; Trinh L; Morrissey MM; Kochanny MJ
    Bioorg Med Chem Lett; 2003 Feb; 13(3):507-11. PubMed ID: 12565961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of a series of benzothiophene-derived NPY Y1 antagonists: optimization of the C-2 side chain.
    Britton TC; Spinazze PG; Hipskind PA; Zimmerman DM; Zarrinmayeh H; Schober DA; Gehlert DR; Bruns RF
    Bioorg Med Chem Lett; 1999 Feb; 9(3):475-80. PubMed ID: 10091705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of benzo[b]thiophene-based medicinal chemistry.
    Keri RS; Chand K; Budagumpi S; Balappa Somappa S; Patil SA; Nagaraja BM
    Eur J Med Chem; 2017 Sep; 138():1002-1033. PubMed ID: 28759875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships of benzo[b]thienylallylamine antimycotics.
    Nussbaumer P; Petranyi G; Stütz A
    J Med Chem; 1991 Jan; 34(1):65-73. PubMed ID: 1992153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient synthesis and 5-LOX/COX-inhibitory activity of some 3-hydroxybenzo[b]thiophene-2-carboxylic acid derivatives.
    Hansen FK; Khankischpur M; Tolaymat I; Mesaros R; Dannhardt G; Geffken D
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5031-4. PubMed ID: 22749420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C2 Arylated Benzo[b]thiophene Derivatives as Staphylococcus aureus NorA Efflux Pump Inhibitors.
    Liger F; Bouhours P; Ganem-Elbaz C; Jolivalt C; Pellet-Rostaing S; Popowycz F; Paris JM; Lemaire M
    ChemMedChem; 2016 Feb; 11(3):320-30. PubMed ID: 26732895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.